Critical Reviews in Clinical Laboratory Sciences

Papers
(The H4-Index of Critical Reviews in Clinical Laboratory Sciences is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19: from an acute to chronic disease? Potential long-term health consequences237
Current concepts and advances in biomarkers of acute kidney injury102
Vitamin B12status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls75
The COVID-19 pandemic: viral variants and vaccine efficacy73
Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites73
Potential value and impact of data mining and machine learning in clinical diagnostics62
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review61
Molecular diagnostic assays for COVID-19: an overview52
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath29
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases28
Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: advances, challenges, and opportunities27
Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research26
Oligoclonal bands: clinical utility and interpretation cues21
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-1921
The potential impact of salivary peptides in periodontitis20
Lean and Six Sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory19
T helper cells in depression: central role of Th17 cells19
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future19
Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done19
0.051062107086182